Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
This study has been completed.
Study NCT01349998   Information provided by Tinea Pharmaceuticals

First Received on May 3, 2011.   Last Updated on January 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tinea Pedis
Tinea Cruris
Tinea Corporis
Additional conditions recognized in this trial
Tinea
More general conditions related to this trial
Dermatomycoses
Foot Dermatoses
Foot Diseases
Infection
Mycoses
Pruritus
Signs and Symptoms
Skin Diseases
Skin Diseases, Infectious
Skin Manifestations
Interventions listed in this trial
Product 33525
Sponsors listed in this trial
Tinea Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services